English Polski
Online first
Review paper
Published online: 2024-10-24

open access

Page views 17
Article views/downloads 12
Get Citation

Connect on Social Media

Connect on Social Media

Heat-shock protein 27 (HSP27) not just a biomarker of cardiac and renal diseases

Kamila Bołtuć-Dziugieł1, Robert Dziugieł1, Andrzej Jaroszyński1
DOI: 10.5603/aa.97350

Abstract

Heat-shock proteins (HSPs) are a large family of conserved chaperone proteins which provide cell protection
from various forms of stress including inflammation, hypoxia, ischaemia, and apoptosis. Heat-shock protein
27 (HSP27) is a member of a small molecular weight HSP family and it has recently been connected with
cardiac and renal disorders. Several studies stated that HSP27 can be a reliable predictor of cardiac events in
patients with chronic heart failure. Moreover, there is a strong inverse relationship between HSP27 level and
atherosclerosis. Interestingly, the HSP27 level in atherosclerosis plaques was significantly lower compared to
healthy arteries. Additionally, HSP27 was linked with atrial fibrillation (AF) and acute chest pain. Various studies
also reported HSP27’s usefulness in renal disorders. HSP27 seems to be an independent predictor of not only
cardiovascular mortality but also sudden cardiac death (SCD) among haemodialysed (HD) patients. Collaterally
HSP27 was proposed as a marker of chronic kidney disease, contrast-induced acute kidney injury (AKI) as well
as AKI associated with liver ischaemia-reperfusion injury. Observations from studies conducted to date suggest
that HSP27 may be a valuable marker for cardiovascular and nephrological diseases and even a possible therapeutic
target. However, to fully understand the role of HSP27 in these diseases, further studies are required.

Article available in PDF format

View PDF Download PDF file

References

  1. Vidyasagar A, Wilson NA, Djamali A. Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair. 2012; 5(1): 7.
  2. Rodríguez-Iturbe B, Johnson RJ. Heat shock proteins and cardiovascular disease. Physiol Int. 2018; 105(1): 19–37.
  3. Bakthisaran R, Tangirala R, Rao ChM. Small heat shock proteins: Role in cellular functions and pathology. Biochim Biophys Acta. 2015; 1854(4): 291–319.
  4. Hu C, Yang J, Qi Z, et al. Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities. MedComm (2020). 2022; 3(3): e161.
  5. Martínez-Laorden E, Navarro-Zaragoza J, Milanés MV, et al. Cardiac Protective Role of Heat Shock Protein 27 in the Stress Induced by Drugs of Abuse. Int J Mol Sci. 2020; 21(10).
  6. Ghayour-Mobarhan M, Saber H, Ferns GAA. The potential role of heat shock protein 27 in cardiovascular disease. Clin Chim Acta. 2012; 413(1-2): 15–24.
  7. Junho CV, Azevedo CA, da Cunha RS, et al. Heat Shock Proteins: Connectors between Heart and Kidney. Cells. 2021; 10(8).
  8. Talkhi N, Nooghabi MJ, Esmaily H, et al. Prediction of serum anti-HSP27 antibody titers changes using a light gradient boosting machine (LightGBM) technique. Sci Rep. 2023; 13(1): 12775.
  9. De AK, Roach SE. Detection of the soluble heat shock protein 27 (hsp27) in human serum by an ELISA. J Immunoassay Immunochem. 2004; 25(2): 159–170.
  10. Marx V. Targeted proteomics. Nat Methods. 2013; 10(1): 19–22.
  11. Holguin BA, Hildenbrand ZL, Bernal RA. Insights Into the Role of Heat Shock Protein 27 in the Development of Neurodegeneration. Front Mol Neurosci. 2022; 15: 868089.
  12. Jaroszyński A, Jaroszyńska A, Zaborowski T, et al. Serum heat shock protein 27 levels predict cardiac mortality in hemodialysis patients. BMC Nephrol. 2018; 19(1): 359.
  13. Zhang HL, Jia KY, Sun Da, et al. Protective effect of HSP27 in atherosclerosis and coronary heart disease by inhibiting reactive oxygen species. J Cell Biochem. 2019; 120(3): 2859–2868.
  14. Traxler D, Lainscak M, Simader E, et al. Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients. Clin Chim Acta. 2017; 473: 127–132.
  15. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  16. Shan R, Liu N, Yan Y, et al. Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27. Pharmacol Res. 2021; 166: 105169.
  17. Martin-Ventura JL, Duran MC, Blanco-Colio LM, et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation. 2004; 110(15): 2216–2219.
  18. Wick G. The heat is on: heat-shock proteins and atherosclerosis. Circulation. 2006; 114(9): 870–872.
  19. Park HK, Park EC, Bae SW, et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation. 2006; 114(9): 886–893.
  20. Shams S, Shafi S, Bodman-Smith K, et al. Anti-heat shock protein-27 (Hsp-27) antibody levels in patients with chest pain: association with established cardiovascular risk factors. Clin Chim Acta. 2008; 395(1-2): 42–46.
  21. Vander Heide RS. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2002; 282(3): H935–H941.
  22. Jin C, Cleveland JC, Ao L, et al. Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4. Mol Med. 2014; 20(1): 280–289.
  23. Brundel BJ, Henning RH, Ke L, et al. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J Mol Cell Cardiol. 2006; 41(3): 555–562.
  24. Marion DM, Lanters EAH, Ramos KS, et al. Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation. Cells. 2020; 9(9).
  25. van Marion DMS, Ramos KS, Lanters EAH, et al. Atrial heat shock protein levels are associated with early postoperative and persistence of atrial fibrillation. Heart Rhythm. 2021; 18(10): 1790–1798.
  26. Kargari M, Tavassoli S, Avan A, et al. Relationship between serum anti-heat shock protein 27 antibody levels and obesity. Clin Biochem. 2017; 50(12): 690–695.
  27. Dillmann WH. Small Heat Shock Proteins an Protection. Proteins n d. : 618–20.
  28. Jaroszyński A, Schlegel TT, Mosiewicz J, et al. Heat Shock Protein 27 Levels Predict Myocardial Inhomogeneities in Hemodialysis Patients. Mediators Inflamm. 2022; 2022: 5618867.
  29. Kardys I, Kors JA, van der Meer IM, et al. Spatial QRS-T angle predicts cardiac death in a general population. Eur Heart J. 2003; 24(14): 1357–1364.
  30. Lebherz-Eichinger D, Ankersmit HJ, Hacker S, et al. HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease. Clin Chim Acta. 2012; 413(1-2): 282–286.
  31. Musiał K, Zwolińska D. Hsp27 as a marker of cell damage in children on chronic dialysis. Cell Stress Chaperones. 2012; 17(6): 675–682.
  32. Krasinski Z, Krasińska B, Olszewska M, et al. Acute Renal Failure/Acute Kidney Injury (AKI) Associated with Endovascular Procedures. Diagnostics (Basel). 2020; 10(5).
  33. Andreucci M, Faga T, Pisani A, et al. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. ScientificWorldJournal. 2014; 2014: 823169.
  34. Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014; 7(1): 1–9.
  35. Pistolesi V, Regolisti G, Morabito S, et al. Contrast medium induced acute kidney injury: a narrative review. J Nephrol. 2018; 31(6): 797–812.
  36. O'Neill S, Harrison EM, Ross JA, et al. Heat-shock proteins and acute ischaemic kidney injury. Nephron Exp Nephrol. 2014; 126(4): 167–174.
  37. Marquez E, Sadowski E, Reese S, et al. Serum HSP27 is associated with medullary perfusion in kidney allografts. J Nephrol. 2012; 25(6): 1075–1080.
  38. Jaroszyński A, Zaborowski T, Głuszek S, et al. Heat Shock Protein 27 Is an Emerging Predictor of Contrast-Induced Acute Kidney Injury on Patients Subjected to Percutaneous Coronary Interventions. Cells. 2021; 10(3).
  39. Park SW, Chen SWC, Kim M, et al. Human heat shock protein 27-overexpressing mice are protected against acute kidney injury after hepatic ischemia and reperfusion. Am J Physiol Renal Physiol. 2009; 297(4): F885–F894.
  40. Guo Q, Du X, Zhao Y, et al. Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats. Mol Med Rep. 2014; 10(6): 2875–2881.